Store launching soon — browse the catalog and join the waitlist to be notified at launch.
✦USPS Priority Mail1–3 day delivery across the U.S.Free on orders over $200
Store launching soon — browse the catalog and join the waitlist to be notified at launch.
Your cart is empty
Mitochondrial Blend
Also known as NAD+ 100mg + 5-Amino-1MQ 10mg + MOTS-c 10mg
Mito-Genesis is a research blend supplying NAD+, 5-Amino-1MQ, and MOTS-c in a single vial.
🚀 Launching soon — join the waitlist to be notified when this product is available.
This product is intended strictly for laboratory research use within Canada. It is not approved by Health Canada for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable Canadian regulations.
Mito-Genesis is a research blend supplying NAD+, 5-Amino-1MQ, and MOTS-c in a single vial.
Each component is studied separately in mitochondrial and metabolic research; the blend itself has no combined published literature.
Third-party tested for purity, ID, quantity.
Mito-Genesis combines three compounds associated with mitochondrial and metabolic research. NAD+ is a central redox cofactor whose decline is a recurring theme in cellular-ageing work. 5-Amino-1MQ is a small-molecule NNMT inhibitor studied for effects on nicotinamide salvage. MOTS-c is a mitochondrial-derived peptide characterized for metabolic homeostasis and nuclear gene regulation under metabolic stress.
The combination is a formulation choice, not a studied entity. References below are drawn from the component literature.
Each component entered research independently: NAD+ through decades of redox-biology work, 5-Amino-1MQ through NNMT inhibitor screening, and MOTS-c through the discovery of mitochondrial-derived peptides in the 2010s.
Blending them into a single research vial is a supplier formulation with no separate development history.
Research relevant to Mito-Genesis is the sum of its components: mitochondrial-derived peptide signaling, NAD+ redox metabolism, and NNMT inhibition. No study has evaluated this specific three-component combination.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each unit contains the labeled quantity of Mito-Genesis. Independent third-party analysis verifies purity, identity, and net content per batch.
The unit contains only the research compound. Any laboratory materials required for reconstitution or experimental procedures must be sourced separately.
Duration depends entirely on research design, storage conditions, and laboratory protocol.
The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance.
PubMedThe NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity.
PubMedStructure-Activity Relationship for Small Molecule Inhibitors of Nicotinamide N-Methyltransferase. J Med Chem 60(13):5015–5028.
PubMedRelated
Pentadecapeptide studied for angiogenesis signaling, tissue repair pathways, and cellular regeneration research
From$50.00
$60.00
Small molecule studied for metabolic regulation, NAD pathways, and cellular energy signaling
From$40.00
Dual peptide complex studied for actin signaling, tissue regeneration pathways, and recovery system research
From$0.00
Oral peptide format studied for systemic repair signaling and gastrointestinal pathway research
$140.00
